Articles About generic competition
March 03, 2014
Teva may find its new formula of Copaxone is a tough sell for insurers; the company is desperate to convert patients.
February 14, 2014
Pfizer's Australian unit is being sued by a federal regulator there for allegedly deterring competition of its generic version of the top-selling Lipitor.
February 11, 2014
Merck & Co. Inc. announced Monday that it's partnering with Samsung Bioepis to create a generic version of Sanofi SA's best-selling insulin drug.
February 07, 2014
Pfizer won a court ruling that effectively blocks generic competition for its top-selling pain medicine, Lyrica, until December 2018.
February 03, 2014
Novartis will cut as many as 4,000 jobs as part of a restructuring plan that reallocates resources for planned product launches and other new growth areas.
January 24, 2014
When releasing earnings last October, Novartis noted that the hit to earnings the release of the generic version of Diovan would come in 2014.